BDBM50313179 (R)-2-((S)-1-ethyl-3-methyl-4-(4-(trifluoromethyl)phenethyl)-6,7-dihydro-1H-pyrazolo[4,3-c]pyridin-5(4H)-yl)-N-methyl-2-phenylacetamide::CHEMBL1081252

SMILES CCn1nc(C)c2[C@H](CCc3ccc(cc3)C(F)(F)F)N(CCc12)[C@@H](C(=O)NC)c1ccccc1

InChI Key InChIKey=VDTFQQQTVJPZLY-WIOPSUGQSA-N

Data  2 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 50313179   

TargetOrexin receptor type 2(Homo sapiens (Human))
Actelion Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50313179((R)-2-((S)-1-ethyl-3-methyl-4-(4-(trifluoromethyl)...)
Affinity DataIC50:  3nMAssay Description:Antagonist activity at human OX2 receptor expressed in CHO cells assessed as inhibition of calcium mobilization by FLIPR assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetOrexin/Hypocretin receptor type 1(Homo sapiens (Human))
Actelion Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50313179((R)-2-((S)-1-ethyl-3-methyl-4-(4-(trifluoromethyl)...)
Affinity DataIC50:  128nMAssay Description:Antagonist activity at human OX1 receptor expressed in CHO cells assessed as inhibition of calcium mobilization by FLIPR assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed